RAC1 #SUMOylation emerges as a druggable regulator of #BreastCancer #Metastasis. Blocking this switch with TAT-PRASI reduces RAC1 activity and RAC1–POTEE interaction, impairing invadopodia formation and metastatic invasion. @usaloficial.bsky.social @ucm.es
#STTT #OpenAccess: doi.org/10.1038/s413...
@sigtrans-sttt.bsky.social
@newphyt.bsky.social